Corticosteroids in Covid-19 pandemic have the potential to unearth hidden burden of strongyloidiasis

COVID-19 pandemic has posed formidable public health and clinical challenges to the entire humanity. A significant proportion of the COVID-19 patients have been provided immunosuppressive agents, particularly corticosteroids, as a part of management of moderate to severe COVID-19 disease. This has t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gautam, Disha, Gupta, Ayush, Meher, Adarsh, Siddiqui, Farha, Singhai, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197611/
https://www.ncbi.nlm.nih.gov/pubmed/34150517
http://dx.doi.org/10.1016/j.idcr.2021.e01192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197611/
https://www.ncbi.nlm.nih.gov/pubmed/34150517
http://dx.doi.org/10.1016/j.idcr.2021.e01192

Ejemplares similares